Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies
Clinical trial NCT04865159 · TERMINATED
Trial details
- NCT number
- NCT04865159
- Sponsor
- Kura Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2023-05-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.